<DOC>
	<DOCNO>NCT00219986</DOCNO>
	<brief_summary>Monoclonal antibody infusion prevent rebound viremia well-suppressed HAART-treated individual begin therapy acute early HIV-1 infection .</brief_summary>
	<brief_title>Phase I/II , Open-Label Trial Three Monoclonal Antibodies</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>HIV1 infection , document licensed ELISA test kit confirm Western blot time prior study entry . Acute early HIV1 infection time HAART initiation define HIV1 RNA detectable negative serology negative detuned ELISA . HAART least 15 month 1 detectable HIV1 RNA value ( 50 copy/mL ) least 6 month prior screen . Laboratory value Absolute neutrophil count ( ANC ) equal greter 750/mm3 . Hemoglobin equal great 9.5 g/dL . Platelet count equal great 50,000/mm3 . Calculated creatinine clearance ( CrCl ) equal great 80 mL/min accord CockcroftGault formula : Men : ( 140age year ) x ( wt kg ) = CrCl ( mL/min ) 72 x ( serum creatinine mg/dL ) Female : ( 140age year ) x ( wt kg ) x 0.85 = CrCl ( mL/min ) 72 x ( serum creatinine mg/dL ) AST ( SGOT ) , ALT ( SGPT ) , alkaline phosphatase equal le 5 x ULN . Total bilirubin equal less 2.5 x ULN . Serum Lipase equal less 1.5 x ULN Negative serum pregnancy test within 14 day . All female childbearing potential must agree practice active birth control measure ( barrier method condom , diaphragm , cervical cap , etc . intrauterine device coil ) avoid pregnancy receive study drug 30 day last dose study drug . Additionally , men enrol study practice active birth control period time female partner childbearing potential . Men woman age &gt; 18 year . Ability willingness subject give write informed consent More 1 detectable HIV1 RNA value ( &gt; 50 copies/mL ) within 6 month screen visit Pregnancy breastfeeding . Active drug alcohol use dependence , opinion investigator , would interfere adherence study requirement . Serious illness ( require systemic treatment and/or hospitalization ) subject either complete therapy clinically stable therapy , opinion investigator , least 30 day prior study entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Treatment Experienced</keyword>
	<keyword>HIV</keyword>
</DOC>